ProSpectral™

Fast, Accurate, Multiple Disease Screening

Explainable Artificial Intelligence

PCI’s Pattern Discovery Engine is the world’s first commercial platform delivering the ability to transparently understand the salient factors driving the predictions and insights from the most advanced analytical models in use today.

(XAI)

READ MORE

Pattern Discovery Engine™

PCI’s PDE is the world’s first commercial platform delivering deep insights into the core challenges facing your business

READ MORE

[

WELCOME TO THE WORLD’S FIRST
PATTERN DISCOVERY ENGINE

]

Pattern Computer is not just another machine learning or AI company: the PCI team has developed a new, innovative, end-to-end system, the Pattern Discovery Engine™, for generating new hypotheses and insights from highly dimensional data to help you transform the speed, efficiency, and effectiveness of your research, business operations or development of new materials or products and services.

LEARN MORE

See more videos on our YouTube Channel HERE

CURRENT INNOVATIONS

Pattern To Attend and Present at Biotech Showcase 2025 and the 43rd Annual J.P. Morgan Healthcare Conferences

Pattern to Attend Fortune Brainstorm AI 2024 Conference

Pattern Announces Company Presentation at BIO-Europe 2024

Pattern Computer Discovers New and Novel Methods for Reducing Flight Delays

Pattern To Test Novel AI-Discovered Molecular De Novo Drug for Treatment of Multiple Hard-to-Treat Cancers

Pattern Computer Brings Autonomous Risk and Confidence Tools to XAI

Pattern to Host Advanced AI Day at FiRe2023 Conference

The problem with AI neural networks, and more predictions about the future of technology

Pattern Computer Reveals Groundbreaking New Technology for Explainable AI at the FiRe22 Conference

Pattern Computer Releases Seminal Paper on the foundations of Explainable AI

Latest News

Pattern To Test Novel AI-Discovered Molecular De Novo Drug for Treatment of Multiple Hard-to-Treat Cancers

Scott2025-06-18T18:16:06+00:00June 18, 2025|

Working with data from the Fred Hutch Cancer Center, and the Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO), Pattern identified a novel drug target that is not actively expressed in any adult tissue, [...]